We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Levicept Stock

Invest in or calculate the value of your shares in Levicept or other pre-IPO companies through EquityZen's platform.

Get Started

Levicept Stock

Levicept develops biological agent for the treatment of chronic pain.

About Levicept Stock

Founded

2012

Industries

Software, Artificial Intelligence, Data and Analytics

With more than 1 billion people worldwide living with some type of chronic pain, a large unmet medical need for safe and effective analgesics exists. Traditional non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used drugs to treat pain and inflammation associated with osteoarthritis, but their use is limited by adverse effects on gastrointestinal and platelet function, as well as increased cardiovascular liability. Levicept is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are progressing LEVI-04 to phase I clinical trials to test its efficacy and safety in patients with osteoarthritis.
Locked Features

Join now and verify your accreditation status to gain access to:

  • Levicept Current Valuation
  • Levicept Stock Price
  • Levicept Management
  • Available deals in Levicept and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Levicept Cap Table and Funding History by Share Class and Liquidity Preferences
    • Levicept Revenue and Financials
    • Levicept Highlights
    • Levicept Business Model
    • Levicept Risk Factors
  • Levicept Research Report from SACRA Research
Join Now

Trading Levicept Stock

How to invest in Levicept stock?

Accredited investors can buy pre-IPO stock in companies like Levicept through EquityZen funds. These investments are made available by existing Levicept shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Levicept stock?

Shareholders can sell their Levicept stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Levicept